BWX Technologies (NYSE:BWXT) Issues Quarterly Earnings Results

BWX Technologies (NYSE:BWXT) announced its quarterly earnings results on Monday. The technology company reported $1.08 EPS for the quarter, beating the consensus estimate of $0.91 by $0.17, Zacks reports. BWX Technologies had a return on equity of 30.70% and a net margin of 10.04%.The business had revenue of $885.84 million during the quarter, compared to analysts’ expectations of $837.47 million. BWX Technologies updated its FY 2026 guidance to 4.550-4.700 EPS.

Here are the key takeaways from BWX Technologies’ conference call:

• BWXT closed a record 2025 with revenue up 18%, Adjusted EBITDA up 15%, EPS up 20%, free cash flow up 16%, and a year-end backlog of $7.3 billion (up 15% YoY).
• Commercial operations drove the quarter — Q4 commercial revenue rose 95% (31% organic) and commercial backlog reached $1.7 billion (up 85% YoY), while BWXT Medical surpassed $100 million in annual revenue with continued double‑digit growth expected.
• Strategic M&A and investments accelerated capability and wins — the AOT and Kinectrics acquisitions supported awards including a $1.6 billion high‑purity depleted uranium contract and an owner’s‑engineer role for the AP1000 in Bulgaria, plus new facilities (Innovation Campus, Centrifuge facility, Digital Center) to scale advanced nuclear and special materials.
• Financial position strengthened — BWXT completed a $1.25 billion 0% convertible, increased liquidity to $1.7 billion, reduced interest costs, and guided 2026 to ~$3.75 billion revenue, Adjusted EBITDA $645–660M, EPS $4.55–4.70, and FCF $305–320M.
• Near‑term margin and cadence risks — government revenue/EBITDA were slightly down in Q4, new government programs begin at lower initial margins, and management expects ~55% of EBITDA to be back‑half weighted with Q1 EBITDA likely flat, implying short‑term pressure on margins and quarterly results.

BWX Technologies Stock Performance

NYSE:BWXT traded down $7.38 during mid-day trading on Monday, reaching $199.06. 971,235 shares of the company’s stock were exchanged, compared to its average volume of 1,035,049. BWX Technologies has a one year low of $84.21 and a one year high of $220.57. The business’s fifty day simple moving average is $195.15 and its two-hundred day simple moving average is $186.65. The firm has a market capitalization of $18.20 billion, a PE ratio of 59.78, a price-to-earnings-growth ratio of 3.32 and a beta of 0.83. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.62 and a current ratio of 1.71.

Insider Buying and Selling

In related news, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the completion of the transaction, the chief executive officer directly owned 177,594 shares in the company, valued at $36,097,756.44. This represents a 5.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.47% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On BWX Technologies

Several large investors have recently added to or reduced their stakes in BWXT. Wedbush Securities Inc. increased its position in shares of BWX Technologies by 4.3% during the fourth quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company’s stock valued at $218,000 after acquiring an additional 52 shares during the last quarter. Guggenheim Capital LLC lifted its holdings in BWX Technologies by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 2,598 shares of the technology company’s stock worth $449,000 after purchasing an additional 55 shares in the last quarter. Corient Private Wealth LLC lifted its holdings in shares of BWX Technologies by 1.2% in the second quarter. Corient Private Wealth LLC now owns 5,880 shares of the technology company’s stock worth $847,000 after buying an additional 69 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its holdings in shares of BWX Technologies by 1.0% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 9,331 shares of the technology company’s stock worth $1,613,000 after purchasing an additional 88 shares during the period. Finally, AlTi Global Inc. increased its stake in BWX Technologies by 1.6% in the 4th quarter. AlTi Global Inc. now owns 5,884 shares of the technology company’s stock worth $1,017,000 after acquiring an additional 90 shares during the last quarter. Institutional investors and hedge funds own 94.39% of the company’s stock.

Analysts Set New Price Targets

BWXT has been the topic of a number of research reports. BNP Paribas Exane assumed coverage on BWX Technologies in a research note on Thursday, January 15th. They set a “neutral” rating and a $215.00 price target on the stock. Bank of America increased their price objective on shares of BWX Technologies from $220.00 to $230.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Weiss Ratings lowered shares of BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 26th. Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Northland Securities set a $225.00 price target on BWX Technologies in a research report on Tuesday, November 4th. Three equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $199.20.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.